A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer

NCT02989584 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer
Metastatic Bladder Cancer
Urothelial Carcinoma

Interventions

DRUG: Atezolizumab
DRUG: Gemcitabine
DRUG: Cisplatin

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]